FILE PHOTO: A woman holds a small bottle labeled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken. JERUSALEM: An Israeli research institute that is overseen by the Defence Ministry intends to begin human trials for a potential COVID-19 vaccine as early as October, Defence Minister Benny Gantz said on Thursday .
The Israel Institute of Biological Research would start the trials in conjunction with the Health Ministry after a series of Jewish holidays ends in October, Gantz said. The IIBR has been working on a vaccine for six months and began animal trials in March."All the initial experiments that have been successful ... give great hope," Gantz said after touring the institute in Ness Ziona, about 25 km south of Tel Aviv.
US Ambassador to Israel David Friedman visited the institute's bio-chemical defence laboratory last month and was briefed on a coronavirus vaccine prototype for which it is seeking preliminary US Food and Drug Administration regulation.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Human trials of COVID-19 vaccine set to begin in IndonesiaHuman trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US announces clinical trial of antibody treatment for Covid-19WASHINGTON (AFP) - The US has begun late stage clinical trials into a drug formulated to fight Covid-19, officials said on Tuesday (Aug 4).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Novavax reports promising early trial results of Covid-19 vaccine[WASHINGTON] US biotech company Novavax on Tuesday announced its experimental Covid-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Novavax reports promising early trial results of COVID-19 vaccineUS biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial. The company was given $1.6 billion by the US government
Source: YahooSG - 🏆 3. / 71 Read more »
No fans at Indy 500 as COVID-19 cases surge in IndianaREUTERS: The Indianapolis 500 will not have any spectators in attendance after the Indianapolis Motor Speedway (IMS) reversed direction on ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Tennis: Rafael Nadal to skip US Open due to COVID-19 concernsNEW YORK: World number two Rafael Nadal confirmed on Tuesday (Aug 4) that he will not defend his US Open crown this year at Flushing Meadows as ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »